Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Racing industry cracks down on doping
sport horses
"There is no current evidence that the use of anabolic steroids or other similar substances is endemic in British racing."

Zero tolerance of anabolic steroids to be introduced

Under new anti-doping rules published on February 24, the British horse racing industry will take a zero tolerance approach to anabolic steroids.

Tough new rules will come into force from March 2, in a bid to tackle doping in equine sports. Published by the British Horseracing Authority (BHA), the Equine Anti-Doping Rules state that no horse should be administered anabolic steroids during its racing life, with no exceptions.

In addition, horses will need to be registered from a younger age - initially within 12 months of birth. Over a two-year period, this will be phased to six months.

Anyone found to have administered anabolic steroids will face heftier penalties. There will be a mandatory stand down period of 12 months from training and the horse will not be eligible to start in any race in Britain for 14 months.

The BHA will also have greater access for testing registered horses and more control over horses running in Britain from international jurisdictions.

First announced in June last year, the zero tolerance policy on steroids aims to ensure British racing is at the helm of tackling one of the biggest threats to any sport globally.

BHA's chief executive Nick Rust said: "We hope that the steps we have taken will lead other nations to follow suit and implement rules that are as stringent as ours, for the good of the sport and the horse."

The new rules were borne of a lengthy consultation process, which launched in 2013 following the Godolphin scandal, where numerous horses at a thoroughbred racing stable in Newmarket tested positive for anabolic steroids.

Mr Rust commented: "There is no current evidence that the use of anabolic steroids or other similar substances is endemic in British racing. We showed in 2013 that when it does take place we are able to detect it and act on it. But we must never be complacent."

Long term, it is thought that hair sampling will play an important role in the BHA's testing methods, as it can detect substances that have been administered over a longer period of time than blood and urine tests.

For some time, hair sampling has been used only occasionally, but it is expected it will become more frequent as the new rules are bedded in. James Stier, director of raceway operations and regulation at BHA said it will become "a significant tool in our armoury".

Alongside the new rules, the BHA published a guide to explain what is required of those responsible for a horse. It has been sent to relevant bodies nationally and internationally, as well as to all licensed trainers and registered owners in Britain.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.